procyanidin has been researched along with Hepatitis D in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aizaki, H; Hojima, T; Isogawa, M; Iwamoto, M; Kojima, S; Mizokami, M; Omagari, K; Saito, A; Sugiyama, M; Sureau, C; Suzuki, R; Tanaka, Y; Tsukuda, S; Wakita, T; Watashi, K | 1 |
1 other study(ies) available for procyanidin and Hepatitis D
| Article | Year |
|---|---|
A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins.
Topics: Antiviral Agents; Forecasting; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Molecular Targeted Therapy; Proanthocyanidins; Viral Structural Proteins | 2017 |